3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
2
Urinary Bladder Neoplasms
1
Precancerous Conditions
1
Polyps
1
Neoplastic Syndromes, Hereditary
1
Mouth Neoplasms
1
Keratosis, Actinic
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Genetic Diseases, Inborn
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Duodenal Neoplasms
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Adenomatous Polyps
1
Adenomatous Polyposis Coli
1
Adenoma
1
Interventions
Fluorouracil
3
Docetaxel
3
Oxaliplatin
2
Leucovorin
2
trametinib
1
milk-thistle extract
1
halofantrine
1
dabrafenib
1
Ursodeoxycholic Acid
1
Silymarin
1
Nadroparin
1
Irinotecan
1
Heparin, Low-Molecular-Weight
1
Drug Therapy
1
Cisplatin
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Gastrointestinal Neoplasms
×
Celecoxib
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled